Exercise of Options and Total Voting Rights
Cambridge Cognition Holdings PLC announced the issuance and allotment of 589,287 new ordinary shares, each with a nominal value of 1 pence, following the exercise of share options. Application has been made for these new shares to be admitted to trading on AIM, with dealings expected to commence on September 30, 2025. Following this admission, the company's total number of ordinary shares in issue will be 46,629,700. This figure can be used by shareholders to determine if they need to notify their interest in the company's share capital under the FCA's rules.
Select text to share a quote on X · sign in to keep highlights & notes in your COG notes
Cambridge Cognition Holdings plc (AIM: COG), the brain health software group specialising in digital health products that advance brain health research and treatment, announces that it has issued and allotted 589,287 new ordinary shares of 1 pence each in the capital of the Company (the "New Ordinary Shares") following an exercise of share options.
Application has been made to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM, with dealings expected to commence on 30 September 2025 ("Admission").
Following Admission, the Company will have a total of 46,629,700 Ordinary Shares in issue. Shareholders may use this figure of 46,629,700 Ordinary Shares as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.